Clinical trial
AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding
NCT04804345 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2021
- Completion date
- August 31, 2021
- Enrollment
- 693 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac surgery, cardiopulmonary bypass, high risk bleeding